Exelixis EXEL
NASDAQ EXEL
$59.02 -0.11 (-0.19%)
As of: Sep 4, 2026 · 3:59 PM EDT

Exelixis (EXEL) Amortizatization of Intangibles (2010 - 2019)

Exelixis (EXEL) posted quarterly Amortizatization of Intangibles of $704000.0 for Q3 2019, down 74.23% year-over-year from $2.7 million in Q3 2018, and up 6.83% quarter-over-quarter from $659000.0 in Q2 2019.

Analysis

Exelixis (EXEL) Amortizatization of Intangibles (2010 - 2019) Analysis & Trends

Exelixis' Amortizatization of Intangibles history runs 9 years deep, the most recent figure standing at $704000.0 for Q3 2019.

  • In Q3 2019, Amortizatization of Intangibles fell 74.23% year-over-year to $704000.0; the TTM figure through Sep 2019 stood at -$6.2 million (down 177.9% YoY), while the FY2018 annual figure was $2.9 million, changed N/A from the prior year.
  • Amortizatization of Intangibles for Q3 2019 stood at $704000.0, up from $659000.0 in the prior quarter.
  • The five-year high for Amortizatization of Intangibles was $7.7 million in Q1 2015, with the low at -$7.7 million in Q1 2019.
  • The 4-year median for Amortizatization of Intangibles is $3.8 million (2015), against an average of $2.7 million.
  • The sharpest annual moves came in 2015 and 2019: Amortizatization of Intangibles advanced 9.83% in 2015, then slumped 74.23% in 2019.
  • Exelixis' Amortizatization of Intangibles stood at $4.8 million in 2015, then gained by 9.19% to $5.3 million in 2016, then slumped by 97.69% to $122000.0 in 2018, then jumped by 477.05% to $704000.0 in 2019.
  • Business Quant data shows EXEL's Amortizatization of Intangibles at $704000.0 in Q3 2019, $659000.0 in Q2 2019, and -$7.7 million in Q1 2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - 4.33 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 678,000.00
10 Exelixis 14.81 Bn 13.97 Bn 608.03 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 27, 2019 704,000.00
Jun 28, 2019 659,000.00
Mar 29, 2019 -7.73 Mn
Dec 28, 2018 122,000.00
Sep 28, 2018 2.73 Mn
Mar 31, 2016 5.29 Mn
Dec 31, 2015 4.84 Mn
Sep 30, 2015 5.30 Mn
Jun 30, 2015 7.22 Mn
Mar 31, 2015 7.68 Mn
Dec 31, 2014 7.71 Mn
Sep 30, 2014 7.51 Mn
Jun 30, 2014 7.33 Mn
Mar 31, 2014 6.99 Mn
Dec 31, 2013 6.85 Mn
Sep 30, 2013 6.65 Mn
Jun 30, 2013 6.48 Mn
Mar 31, 2013 6.31 Mn
Dec 31, 2012 6.13 Mn
Sep 30, 2012 4.15 Mn